| Literature DB >> 20044135 |
Xiang-Qing Zhu1, Xing-Hua Pan, Weibo Wang, Qiang Chen, Rong-Qing Pang, Xue-Min Cai, Andrew R Hoffman, Ji-Fan Hu.
Abstract
Multipotent stem cells have the potential to establish a new field of promising regenerative medicine to treat tissue damage, genetic disorders, and degenerative diseases. However, limited resource of stem cells has turned to be an evitable obstacle in clinical applications. We utilized a simple in vitro epigenetic reprogramming approach to convert skin fibroblasts into multipotent cells. After transient reprogramming, stem cell markers, including Oct4 and Nanog, became activated in the treated cells. The reprogrammed cells were multipotent as demonstrated by their ability to differentiate into a variety of cells and to form teratomas. Genomic imprinting of insulin-like growth factor II (Igf2) and H19 was not affected by this short period of cell reprogramming. This study may provide an alternative strategy to efficiently generate patient-specific stem cells for basic and clinical research, solving major hurdles of virally-induced pluripotent stem (iPS) cells that entail the potential risks of mutation, gene instability, and malignancy. 2009 Elsevier Ltd. All rights reserved.Entities:
Keywords: Induced multipotent stem cells; differentiation; epigenetic reprogramming; fish oocyte extracts; iMS cells; multipotency
Mesh:
Substances:
Year: 2009 PMID: 20044135 PMCID: PMC2909839 DOI: 10.1016/j.biomaterials.2009.12.027
Source DB: PubMed Journal: Biomaterials ISSN: 0142-9612 Impact factor: 12.479